Challenges for the Treatment of Diabetes Mellitus

Author(s): Athanasia K. Papazafiropoulou, Marina S. Kardara, Stavros I. Pappas

Journal Name: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Continued as New Advances on Endocrine Metabolic and Immune Diseases

Volume 5 , Issue 3 , 2011


The present review summarizes the existing literature data regarding the development of newer categories of antidiabetic agents, their mechanism of action and their clinical importance. In this paper, a review of the recent patents for the treatment of diabetes will be presented. In recent years significant achievements have been done, including the development of SGLT2 inhibitors, glucokinase activators as well as the role of free fatty acids and bile acid metabolism in the treatment of diabetes are reviewed.

Keywords: Bile acid synthesis, Low density lipoprotein cholesterol, sodium-coupled glucose transporters, free fatty acids, glucokinase activators, SGLT2 inhibitors, Dapagliflozin, Type 2 diabetes mellitus, Diet-induced obesity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [203 - 209]
Pages: 7
DOI: 10.2174/187221411797265953
Price: $58

Article Metrics

PDF: 21